ArticleBritish journal of cancer2022

Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade.

Tingting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.